Survival Of Diabetic Mice Improved After Transplantation Of Human Embryonic Stem Cell Derived ILCs

Geron Corporation (Nasdaq:GERN) today announced the publication of data showing the successful engraftment of human embryonic stem cell (hESC)-derived pancreatic islet-like clusters (ILCs) in diabetic mice. After transplantation, the ILCs continued to express important pancreatic islet proteins, responded to high levels of glucose in the blood, and extended the survival of recipient animals.

More: continued here

Filed under: Diabetes on October 29th, 2008